Overland Park, Kansas Clinical Trials

A listing of Overland Park, Kansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 10 clinical trials
Cookie Testing  

Cookie Testing

Online studies
Site
(online study)
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
RJ_StudyVirtualF  

Acne

Online studies
Site1_RJ_StudyVirtual1N
(online study)
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
T2

we

Online studies
8260013
(online study) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype.

mental state examination
Accepts healthy volunteers
alzheimer's disease
mini-mental state examination
apolipoprotein e4
University of Kansas Alzheimer's Disease Center
 (3.5 away) Contact site
  • 32 views
  • 20 Sep, 2024
  • +126 other locations
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients

Primary Objective: To determine the effect of venglustat on the rate of total kidney volume (TKV) growth (Stage and estimated glomerular filtration rate (eGFR) decline in patients at risk of rapidly progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Stage 2). Secondary Objectives: To determine the effect of venglustat on the …

chronic kidney disease
ophthalmological examination
antihypertensive therapy
polycystic kidney disease
urine osmolality
Investigational Site Number 8400003
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +80 other locations
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

ESR1
fulvestrant
cancer
metastasis
letrozole
Investigational Site Number 8400027
 (3.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +125 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

gaucher disease
eliglustat
deficiency
imiglucerase
Investigational Site Number 840063
 (7.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +208 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

gaa gene
replacement therapy
deficiency
myozyme
glycogen storage disease type ii
Investigational Site Number 840020
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +168 other locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary …

replacement therapy
deficiency
agalsidase beta
fabrazyme
fabry's disease
Investigational Site Number 840071
 (6.3 away) Contact site
  • 0 views
  • 05 Aug, 2024
  • +125 other locations
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

cancer
complete resection
isatuximab
multiple myeloma
refractory multiple myeloma
Investigational Site Number 8400016
 (4.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations